{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:08:43Z","timestamp":1779422923803,"version":"3.53.1"},"reference-count":55,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Cocaine use has increased both globally and nationally. This trend is accompanied by a rise in clinical complications. The objective of our study was to identify factors observed to be associated with cocaine use disorder, using data from the OPPIDUM program, collecting information directly from patients with substance use disorders recruiting in care or harm reduction facilities. Cocaine users were divided into two groups: cocaine use disorder and simple use. A univariate analysis was performed to compare the groups, followed by a multivariate analysis to identify factors associated with cocaine use disorder. Between 2019 and 2023, 6863 cocaine users (28% of all OPPIDUM participants) from 116 addiction treatment centers were included. Several factors were found to be significantly associated with cocaine use disorder: extreme precariousness (OR\u2009=\u20091.34, 95% CI [1.12\u20131.61],\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.002), cocaine\u2010only use (OR\u2009=\u20091.90, 95% CI [1.45\u20132.50],\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001), alcohol dependence (OR\u2009=\u20091.48, 95% CI [1.30\u20131.68], p\u2009&lt;\u20090.0001), and use of antidepressants and antipsychotics (OR\u2009=\u20092.08, 95% CI [1.37\u20133.16],\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.001; OR\u2009=\u20091.94, 95% CI [1.40\u20132.69],\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). These findings highlight several key factors associated with cocaine use disorder and their clinical implications. The study has limitations: potential selection bias, repeated inclusion of the same users across years, multiple modes of cocaine use, and the exploratory nature of the analyses due to uncontrolled alpha risk. Nevertheless, these insights can help healthcare professionals better understand patient profiles and provide more tailored care and prevention strategies.\n                  <\/jats:p>","DOI":"10.1111\/fcp.70081","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:11:26Z","timestamp":1774516286000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors Associated With Cocaine Use Disorder: Results From the French Nationwide Repeated Cross\u2010Sectional OPPIDUM Study (2019\u20132023)"],"prefix":"10.1111","volume":"40","author":[{"given":"Zenab","family":"Alhamidi","sequence":"first","affiliation":[{"name":"Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance \u2013 Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106 University Hospital, Service de Pharmacologie Clinique et Pharmacosurveillance  Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6857-4698","authenticated-orcid":false,"given":"Cl\u00e9mence","family":"Lacroix","sequence":"additional","affiliation":[{"name":"Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance \u2013 Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106 University Hospital, Service de Pharmacologie Clinique et Pharmacosurveillance  Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4873-6522","authenticated-orcid":false,"given":"Elisabeth","family":"Jouve","sequence":"additional","affiliation":[{"name":"Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance \u2013 Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106 University Hospital, Service de Pharmacologie Clinique et Pharmacosurveillance  Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2604-9673","authenticated-orcid":false,"given":"Thomas","family":"Soeiro","sequence":"additional","affiliation":[{"name":"Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance \u2013 Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106 University Hospital, Service de Pharmacologie Clinique et Pharmacosurveillance  Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7839-9811","authenticated-orcid":false,"given":"C\u00e9line","family":"Eiden","sequence":"additional","affiliation":[{"name":"Addictovigilance Centre, Site Unique de Biologie CHU Montpellier  Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7172-7835","authenticated-orcid":false,"given":"Jo\u00eblle","family":"Micallef","sequence":"additional","affiliation":[{"name":"Centre d'\u00e9valuation et d'information sur la pharmacod\u00e9pendance \u2013 Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106 University Hospital, Service de Pharmacologie Clinique et Pharmacosurveillance  Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"Cocaine\u2014The Current Situation in Europe (European Drug Report 2024) https:\/\/www.euda.europa.eu\/publications\/european\u2010drug\u2010report\/2024\/cocaine_en."},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986712803988839"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360\u20100443.2010.03194.x"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.8049"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2024.03.001"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12815"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12603"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2022.10.003"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.31398"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2024.10.033"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckae144.251"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/15504263.2020.1849887"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1159\/000050711"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12024"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228\u2010014\u20101783\u2010x"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2017.01.010"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2019.09.005"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12738"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2018.09.007"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263\u2010024\u201001095\u2010y"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.2515\/therapie\/2012064"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.encep.2009.03.011"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890423349"},{"key":"e_1_2_11_25_1","unstructured":"Code de la Sant\u00e9 Publique article R5132\u201397[Internet] https:\/\/www.legifrance.gouv.fr\/codes\/article_lc\/LEGIARTI000039659171."},{"issue":"5","key":"e_1_2_11_26_1","first-page":"586","article-title":"Observation of Illicit or Misused Psychotropic Drugs (OPPIDUM): Five Years of Surveillance of Products Consumed by Drug Addicts at Marseille","volume":"51","author":"San Marco J. L.","year":"1996","journal-title":"Th\u00e9rapie"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2024.10.054"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12346"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.08.031"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2018.11.005"},{"key":"e_1_2_11_31_1","unstructured":"Les Prix au D\u00e9tail Courants des Principaux Produits Stup\u00e9fiants depuis 2010\u2014OFDT https:\/\/www.ofdt.fr\/publication\/2025\/les\u2010prix\u2010au\u2010detail\u2010courants\u2010des\u2010principaux\u2010produits\u2010stupefiants\u2010depuis\u20102010\u20102489."},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.07.025"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006\u20103223(97)00426\u20105"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024\u20103205(94)00747\u20100"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091\u20103057(02)00764\u20105"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkz007"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v16n03_08"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxac.2019.04.002"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-805373-7.00021-9"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/13556210020077073"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/13803395.2016.1196165"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20021275"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.07.004"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.05.009"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002950.pub3"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.09.004"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2004.07.012"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/bsl.601"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13571"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2012.12.013"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1037\/1064\u20101297.8.1.133"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606\u2010019\u201005074\u20108"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13r08525"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2016.07.001"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108114"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376\u20108716(02)00328\u20109"}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/fcp.70081","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/fcp.70081","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/fcp.70081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T03:37:40Z","timestamp":1779421060000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/fcp.70081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1111\/fcp.70081"],"URL":"https:\/\/doi.org\/10.1111\/fcp.70081","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"2025-06-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70081"}}